-+ 0.00%
-+ 0.00%
-+ 0.00%

DAPIROLIZUMAB PEGOL PHASE 3 DATA IN SLE PRESENTED AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR) SHOW IMPROVEMENT IN FATIGUE AND REDUCTION IN DISEASE ACTIVITY

Reuters·06/12/2025 05:00:39

Please log in to view news